MLTX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - The lawsuit claims that the defendants made false statements regarding MoonLake's business and prospects, leading to inflated stock prices [1] Company Summary - The allegations suggest that misleading information was disseminated about MoonLake, impacting investor perception and stock valuation [1]